SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-371917
Filing Date
2013-09-19
Accepted
2013-09-19 17:24:06
Documents
3
Period of Report
2013-09-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d598876d8k.htm 8-K 15555
2 EX-99.1 d598876dex991.htm EX-99.1 14195
3 GRAPHIC g598876g88l01.jpg GRAPHIC 3475
  Complete submission text file 0001193125-13-371917.txt   35903
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 131106198
SIC: 2834 Pharmaceutical Preparations